Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis
Launched by BAYLOR COLLEGE OF MEDICINE ·
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special dye called Indocyanine Green (ICG) to help surgeons see the ureters—the tubes that carry urine from the kidneys to the bladder—more clearly during robot-assisted surgery for advanced endometriosis. Endometriosis is a condition where tissue similar to the lining inside the uterus grows outside it, which can cause pain and other problems. The study aims to find out if using ICG can make surgery quicker and safer by reducing the chance of accidentally injuring the ureters.
The trial is for women aged 65 to 74 who are having robotic surgery to treat advanced endometriosis. During surgery, a temporary small tube (called a stent) will be placed in one ureter, and ICG dye will be used to make that ureter glow under special lighting. This helps the surgeon identify it more easily. Each participant will have the dye used on either the left or right side, chosen randomly. The researchers will then compare how well the surgery goes with and without the dye. The study is not yet recruiting participants but will also check if using this dye and stent is safe and practical during surgery.
Gender
FEMALE
Eligibility criteria
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Xiaoming Guan, PhD, MD
Principal Investigator
Department Chair of Minimally Invasive Gynecologic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported